Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Press Releases Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 494

Anodyne Therapy, LLC Develops New Device For Treatment of Foot and Leg Pain

Advertisement

  Anodyne_Therapy_Trusted

 

Anodyne Therapy, LLC Develops New Device for Treatment of Foot and Leg Pain and

Pledges Donation in Honor of World Diabetes Day

 

TAMPA, FLA., November 6th 2009 -- Anodyne Therapy, the leading innovator in infrared light therapy products announces the launch of their newest product, the Anodyne® Freedom 300 -- designed to allow patients to affordably and effectively treat foot and leg pain in the comfort of their own homes. Utilizing cutting edge technology, the intuitive design of the Anodyne® Freedom 300 allows patients to quickly and correctly apply it for maximum results. In addition, Anodyne Therapy has announced that it will donate the proceeds from the sales of this new product on November 16th (World Diabetes Day is Saturday, November 14th) to two international charities supporting people with diabetes, Wound Care Haiti, and the IFD’s Life For a Child.

The Anodyne® Freedom 300, affordably priced at under $600, is particularly effective for patients whose pain is associated with impaired circulation since it is able to temporarily increase circulation to the feet and legs by more than 100%. "We are ecstatic about our customers' acceptance of our Anodyne® Freedom 300 and their exceptionally positive comments about ease of use and pain reduction," said Craig Turtzo, CEO of Anodyne Therapy. "It is so uplifting to hear how we are improving people’s lives by providing meaningful pain reduction to those who have suffered from long-term pain," he added.

Mr. Turtzo stated, "People with diabetes represent a large portion of our patient base for Anodyne® home units as well as the patients seen in the more than 6,000 healthcare facilities that administer professional Anodyne® Therapy treatments. We would like to offer more to the diabetic community than pain relief. Therefore, we are joining thousands of other supporters of Diabetes Awareness Month and of World Diabetes Day to enhance diabetic awareness and education to reduce diabetic foot complications across the globe."

The International Diabetes Federation (IDF), in its statement issued in October 2009, reported that the number of people with diabetes continues to grow rapidly throughout the world with more than 440 million people estimated to be affected within the next 20 years. During their most recent meeting in Montreal, the IDF stressed prevention of complications associated with diabetes prior to their manifestation.

The recipients of Anodyne Therapy's donation will be two non-profit organizations, a start up NPO, "Wound Care Haiti" and the IDF's "Life for a Child Program." The mission of "Wound Care Haiti" is to establish a limb amputation prevention program in Haiti, by providing preventative foot care, supplies and education to the country's diabetic population. Anodyne Therapy has additionally pledged the donation of two Anodyne® Therapy Professional Systems to aid Wound Care Haiti in their efforts. The IDF's "Life for a Child Program" supports children with diabetes globally by providing appropriate medical supplies and education.
 

Note to Editors: Anodyne Therapy, LLC was formed in 2001 and is a privately held company based in Tampa, Florida. Anodyne Therapy is committed to improving the quality of life of patients through the use of its drug-free and topically applied medical devices. Thirteen published peer reviewed studies document the efficacy of Anodyne® Therapy Professional Systems, and over 6,000 healthcare facilities provide professional treatments to patients. For more information about Anodyne Therapy LLC and its technology, the Anodyne® Therapy Systems, and the Anodyne® Freedom 300, visit www.anodynetherapy.com. For more information about the charities "Wound Care Haiti" and "Life for a Child" visit: http://www.woundcarehaiti.org and http://www.lifeforachild.idf.org/ respectively. For more information about World Diabetes Day visit: http://www.worlddiabetesday.org/.

 

For more information:
Jennifer Turtzo
813-342-4432 xt 127
Jen@anodynetherapy.com

 

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 November, 2009 and appeared in  Issue 494

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?



Search Articles On Diabetes In Control